Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute.
Blood. 2013 May 30;121(22):4434-6. doi: 10.1182/blood-2013-04-494849.
In this issue of Blood, Poulain et al demonstrate the high prevalence of the MYD88 L265P somatic mutation in patients with Waldenstrom macroglobulinemia (WM) and provide insight into its biological relevance in the growth and survival of WM.
在本期《Blood》中，Poulain 等人证实了 MYD88 L265P 体细胞突变在 Waldenstrom 巨球蛋白血症（WM）患者中的高发生率，并深入了解了其在 WM 生长和存活中的生物学相关性。
